No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | Acute myeloid leukemia 5 genes, 4 drugs (DrugBank), 41 diseases shown |
[4] BRAF, FLT3, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2 | Adherens junction 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
3 | Adipocytokine signaling pathway 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
4 | Adrenergic signaling in cardiomyocytes 12 genes, 8 drugs (DrugBank), 30 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] SCN5A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
5 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 15 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
6 | Alcoholism 3 genes, 3 drugs (DrugBank), 4 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
7 | Aldosterone synthesis and secretion 5 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
8 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] NR3C2 |
D00443 |
Spironolactone |
[6] 58, 67, 86, 113, 218, 225 |
9 | Alzheimer disease 9 genes, 3 drugs (DrugBank), 33 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
10 | Amoebiasis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
11 | Amphetamine addiction 7 genes, 3 drugs (DrugBank), 33 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
12 | AMPK signaling pathway 6 genes, 6 drugs (DrugBank), 59 diseases shown |
[1] ADRA1A |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
13 | Amyotrophic lateral sclerosis (ALS) 6 genes, 2 drugs (DrugBank), 30 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
14 | Apelin signaling pathway 5 genes, 4 drugs (DrugBank), 48 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
15 | Apoptosis 5 genes, 3 drugs (DrugBank), 2 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
16 | Arachidonic acid metabolism 2 genes, 2 drugs (DrugBank), 16 diseases shown |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
18 | Autophagy - animal 4 genes, 3 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
19 | Autophagy - other 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
20 | Axon guidance 7 genes, 4 drugs (DrugBank), 38 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
21 | B cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
22 | Base excision repair 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
23 | Bile secretion 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
24 | Bladder cancer 4 genes, 3 drugs (DrugBank), 10 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
25 | Breast cancer 8 genes, 8 drugs (DrugBank), 45 diseases shown |
[4] BRAF, FLT4, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
26 | C-type lectin receptor signaling pathway 7 genes, 4 drugs (DrugBank), 39 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
27 | Calcium signaling pathway 29 genes, 21 drugs (DrugBank), 57 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] AVPR1A |
D01236 |
Conivaptan |
[1] 86 |
D07748 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[4] CHRM1, CHRM2, CHRM3, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D07171 |
Sitaxentan |
[1] 86 |
[2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
[1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] PDGFRB |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
28 | cAMP signaling pathway 12 genes, 14 drugs (DrugBank), 31 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[2] CHRM1, CHRM2 |
D02212 |
Ipratropium |
[2] 6, 86 |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
D07171 |
Sitaxentan |
[1] 86 |
29 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
30 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
31 | Cell cycle 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
32 | Cellular senescence 8 genes, 5 drugs (DrugBank), 52 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
33 | Central carbon metabolism in cancer 8 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[5] FLT3, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
34 | cGMP-PKG signaling pathway 26 genes, 18 drugs (DrugBank), 56 diseases shown |
[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D07171 |
Sitaxentan |
[1] 86 |
[2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
D10027 |
Udenafil |
[1] 86 |
D02731 |
Vardenafil |
[3] 13, 86, 299 |
D03260 |
D08668 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
35 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
36 | Chemical carcinogenesis 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
37 | Chemokine signaling pathway 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
38 | Choline metabolism in cancer 5 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
39 | Cholinergic synapse 9 genes, 3 drugs (DrugBank), 5 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
40 | Chronic myeloid leukemia 3 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
41 | Circadian entrainment 5 genes, 3 drugs (DrugBank), 9 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
42 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
43 | Cocaine addiction 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
44 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
45 | Colorectal cancer 4 genes, 3 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
46 | Cortisol synthesis and secretion 5 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
47 | Cushing syndrome 7 genes, 5 drugs (DrugBank), 14 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] BRAF |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
48 | Cytokine-cytokine receptor interaction 5 genes, 4 drugs (DrugBank), 26 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
49 | Dilated cardiomyopathy (DCM) 5 genes, 5 drugs (DrugBank), 15 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
50 | Dopaminergic synapse 9 genes, 6 drugs (DrugBank), 38 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] DRD2 |
D01348 |
Terguride |
[2] 51, 86 |
[3] DRD2, DRD3, DRD4 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
[3] PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] SCN1A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
51 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank), 12 diseases shown |
[1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
D04931 |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
52 | EGFR tyrosine kinase inhibitor resistance 9 genes, 7 drugs (DrugBank), 52 diseases shown |
[4] BRAF, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
53 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 3 drugs (DrugBank), 8 diseases shown |
[1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
54 | Endocrine resistance 6 genes, 6 drugs (DrugBank), 40 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
55 | Endocytosis 2 genes, 3 drugs (DrugBank), 14 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
56 | Endometrial cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
57 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
58 | ErbB signaling pathway 5 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
59 | Estrogen signaling pathway 5 genes, 6 drugs (DrugBank), 15 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
D02271 |
D08233 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
60 | Fc epsilon RI signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
61 | Fc gamma R-mediated phagocytosis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
62 | Fluid shear stress and atherosclerosis 9 genes, 7 drugs (DrugBank), 38 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] KDR |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
63 | Focal adhesion 8 genes, 5 drugs (DrugBank), 16 diseases shown |
[5] BRAF, FLT4, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
64 | FoxO signaling pathway 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
65 | GABAergic synapse 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
66 | Gap junction 9 genes, 10 drugs (DrugBank), 26 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
67 | Gastric acid secretion 4 genes, 3 drugs (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
[1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
68 | Gastric cancer 4 genes, 3 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
69 | Glioma 6 genes, 5 drugs (DrugBank), 41 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
70 | Glucagon signaling pathway 7 genes, 2 drugs (DrugBank), 40 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
71 | Glutamatergic synapse 7 genes, 3 drugs (DrugBank), 33 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
72 | Glutathione metabolism 2 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
73 | GnRH secretion 6 genes, 6 drugs (DrugBank), 12 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
74 | GnRH signaling pathway 6 genes, 4 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
75 | Growth hormone synthesis, secretion and action 6 genes, 4 drugs (DrugBank), 39 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
76 | Hematopoietic cell lineage 7 genes, 7 drugs (DrugBank), 60 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
[2] FLT3, KIT |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
77 | Hepatitis B 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
78 | Hepatitis C 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
79 | Hepatocellular carcinoma 5 genes, 4 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
80 | Herpes simplex virus 1 infection 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
81 | HIF-1 signaling pathway 4 genes, 4 drugs (DrugBank), 48 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
82 | Human cytomegalovirus infection 13 genes, 11 drugs (DrugBank), 72 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
83 | Human immunodeficiency virus 1 infection 7 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
84 | Human papillomavirus infection 6 genes, 7 drugs (DrugBank), 46 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
85 | Human T-cell leukemia virus 1 infection 7 genes, 2 drugs (DrugBank), 39 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
86 | Huntington disease 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
87 | Hypertrophic cardiomyopathy (HCM) 7 genes, 4 drugs (DrugBank), 21 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
88 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
89 | Inflammatory mediator regulation of TRP channels 3 genes, 3 drugs (DrugBank), 23 diseases shown |
[1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
90 | Influenza A 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
91 | Insulin resistance 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
92 | Insulin secretion 5 genes, 3 drugs (DrugBank), 5 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
93 | Insulin signaling pathway 5 genes, 3 drugs (DrugBank), 46 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
94 | JAK-STAT signaling pathway 7 genes, 7 drugs (DrugBank), 51 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
95 | Kaposi sarcoma-associated herpesvirus infection 9 genes, 6 drugs (DrugBank), 57 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
96 | Leishmaniasis 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
97 | Long-term depression 5 genes, 2 drugs (DrugBank), 7 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
98 | Long-term potentiation 8 genes, 4 drugs (DrugBank), 34 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
99 | Longevity regulating pathway 4 genes, 3 drugs (DrugBank), 50 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
100 | Longevity regulating pathway - multiple species 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
101 | MAPK signaling pathway 21 genes, 10 drugs (DrugBank), 53 diseases shown |
[7] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
102 | Melanogenesis 3 genes, 5 drugs (DrugBank), 19 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
103 | Melanoma 5 genes, 4 drugs (DrugBank), 14 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
104 | Metabolic pathways 13 genes, 13 drugs (DrugBank), 49 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
[1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
[1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
D04931 |
[1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
D10027 |
Udenafil |
[1] 86 |
D02731 |
Vardenafil |
[3] 13, 86, 299 |
D03260 |
D08668 |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
105 | MicroRNAs in cancer 8 genes, 8 drugs (DrugBank), 48 diseases shown |
[2] ABL1, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] ABL1, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
106 | Morphine addiction 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
D02271 |
D08233 |
107 | mTOR signaling pathway 5 genes, 3 drugs (DrugBank), 46 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
108 | Natural killer cell mediated cytotoxicity 7 genes, 2 drugs (DrugBank), 31 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
109 | Necroptosis 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
110 | Neuroactive ligand-receptor interaction 31 genes, 26 drugs (DrugBank), 70 diseases shown |
[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[2] AVPR1A, AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
D07748 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
[3] DRD2, DRD3, DRD4 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
[2] DRD2, PRL |
D01348 |
Terguride |
[2] 51, 86 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D07171 |
Sitaxentan |
[1] 86 |
[2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
[1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
[1] NR3C1 |
D00407 |
Methylprednisolone |
[36] 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
D00751 |
D00979 |
D05000 |
D05001 |
D05002 |
D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
[1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
D02271 |
D08233 |
[1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
D00106 |
Epoprostenol |
[1] 86 |
D01337 |
D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
D10725 |
Ralinepag |
[1] 86 |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
[1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
[1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
111 | Neurotrophin signaling pathway 4 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
112 | NF-kappa B signaling pathway 3 genes, 4 drugs (DrugBank), 29 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] PARP1 |
D09730 |
Olaparib |
[1] 86 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
113 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 3 drugs (DrugBank), 30 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
114 | Non-small cell lung cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
115 | Oocyte meiosis 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[1] AR |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
116 | Osteoclast differentiation 7 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
117 | Ovarian steroidogenesis 2 genes, 3 drugs (DrugBank), 18 diseases shown |
[1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
118 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
119 | Oxytocin signaling pathway 17 genes, 9 drugs (DrugBank), 54 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
120 | p53 signaling pathway 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
121 | Pancreatic cancer 5 genes, 4 drugs (DrugBank), 38 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
122 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
123 | Parathyroid hormone synthesis, secretion and action 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
124 | Parkinson disease 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
125 | Pathogenic Escherichia coli infection 2 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
126 | Pathways in cancer 22 genes, 19 drugs (DrugBank), 72 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[3] AR, ESR1, ESR2 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
[7] BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D07171 |
Sitaxentan |
[1] 86 |
[2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
127 | PD-L1 expression and PD-1 checkpoint pathway in cancer 8 genes, 4 drugs (DrugBank), 49 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
128 | Phospholipase D signaling pathway 9 genes, 7 drugs (DrugBank), 43 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[2] AVPR1A, AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
D07748 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[3] KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
129 | PI3K-Akt signaling pathway 16 genes, 10 drugs (DrugBank), 61 diseases shown |
[2] CHRM1, CHRM2 |
D02212 |
Ipratropium |
[2] 6, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
[1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
130 | Platelet activation 7 genes, 11 drugs (DrugBank), 21 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] P2RY12 |
D00769 |
Clopidogrel |
[2] 49, 86 |
D07729 |
D10823 |
D10824 |
[1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
D00106 |
Epoprostenol |
[1] 86 |
D01337 |
D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
D10725 |
Ralinepag |
[1] 86 |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
[1] PTGS1 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
131 | Platinum drug resistance 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
132 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
133 | Progesterone-mediated oocyte maturation 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
134 | Prolactin signaling pathway 4 genes, 5 drugs (DrugBank), 10 diseases shown |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
135 | Prostate cancer 8 genes, 7 drugs (DrugBank), 54 diseases shown |
[1] AR |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
136 | Protein processing in endoplasmic reticulum 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
137 | Proteoglycans in cancer 7 genes, 7 drugs (DrugBank), 41 diseases shown |
[3] BRAF, KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
138 | Purine metabolism 6 genes, 7 drugs (DrugBank), 28 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
D04931 |
[1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
D10027 |
Udenafil |
[1] 86 |
D02731 |
Vardenafil |
[3] 13, 86, 299 |
D03260 |
D08668 |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
139 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
140 | Rap1 signaling pathway 10 genes, 7 drugs (DrugBank), 16 diseases shown |
[6] BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
D08132 |
D01348 |
Terguride |
[2] 51, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
141 | Ras signaling pathway 10 genes, 5 drugs (DrugBank), 16 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
142 | Regulation of actin cytoskeleton 10 genes, 5 drugs (DrugBank), 14 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
143 | Regulation of lipolysis in adipocytes 5 genes, 6 drugs (DrugBank), 27 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[3] ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
144 | Relaxin signaling pathway 4 genes, 5 drugs (DrugBank), 16 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
145 | Renal cell carcinoma 3 genes, 2 drugs (DrugBank), 9 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
146 | Renin secretion 18 genes, 14 drugs (DrugBank), 51 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[3] ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
D07171 |
Sitaxentan |
[1] 86 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
147 | Renin-angiotensin system 4 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
[2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
148 | Retrograde endocannabinoid signaling 5 genes, 4 drugs (DrugBank), 18 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
149 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
150 | Salivary secretion 10 genes, 6 drugs (DrugBank), 24 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
D02342 |
[1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
151 | Serotonergic synapse 9 genes, 6 drugs (DrugBank), 22 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] SLC6A4 |
D00326 |
Fluoxetine |
[6] 13, 17, 78, 86, 179, 206 |
D00823 |
152 | Shigellosis 4 genes, 5 drugs (DrugBank), 51 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
153 | Signaling pathways regulating pluripotency of stem cells 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
154 | Small cell lung cancer 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
155 | Sphingolipid signaling pathway 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
156 | Steroid hormone biosynthesis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
157 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] SLC6A4 |
D00326 |
Fluoxetine |
[6] 13, 17, 78, 86, 179, 206 |
D00823 |
158 | T cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
159 | Taste transduction 5 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
[3] SCN2A, SCN3A, SCN9A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
160 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
161 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
162 | Th1 and Th2 cell differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
163 | Th17 cell differentiation 8 genes, 4 drugs (DrugBank), 62 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
164 | Thermogenesis 6 genes, 5 drugs (DrugBank), 53 diseases shown |
[1] ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
165 | Thyroid cancer 3 genes, 2 drugs (DrugBank), 18 diseases shown |
[2] BRAF, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
166 | Thyroid hormone signaling pathway 3 genes, 5 drugs (DrugBank), 40 diseases shown |
[1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
167 | Tight junction 4 genes, 4 drugs (DrugBank), 20 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
168 | TNF signaling pathway 2 genes, 3 drugs (DrugBank), 16 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
169 | Transcriptional misregulation in cancer 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] FLT3 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
170 | Tuberculosis 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
171 | Type II diabetes mellitus 3 genes, 3 drugs (DrugBank), 39 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
172 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
173 | Vascular smooth muscle contraction 16 genes, 18 drugs (DrugBank), 30 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
D03415 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
D02014 |
[1] AVPR1A |
D01236 |
Conivaptan |
[1] 86 |
D07748 |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
D03830 |
D07845 |
D00617 |
Nicardipine |
[2] 70, 86 |
D08270 |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
D07171 |
Sitaxentan |
[1] 86 |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
[1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
D00106 |
Epoprostenol |
[1] 86 |
D01337 |
D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
D10725 |
Ralinepag |
[1] 86 |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
174 | Vasopressin-regulated water reabsorption 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
D07748 |
175 | VEGF signaling pathway 9 genes, 5 drugs (DrugBank), 44 diseases shown |
[2] KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
D08524 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
176 | Viral myocarditis 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
177 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank), 16 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
178 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |